AU601725B2 - An organic zinc complex and its use as an antimycotic - Google Patents

An organic zinc complex and its use as an antimycotic Download PDF

Info

Publication number
AU601725B2
AU601725B2 AU71758/87A AU7175887A AU601725B2 AU 601725 B2 AU601725 B2 AU 601725B2 AU 71758/87 A AU71758/87 A AU 71758/87A AU 7175887 A AU7175887 A AU 7175887A AU 601725 B2 AU601725 B2 AU 601725B2
Authority
AU
Australia
Prior art keywords
zinc
iodo
complex
formula
hydroxyquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU71758/87A
Other languages
English (en)
Other versions
AU7175887A (en
Inventor
Janos Egri
Marton Dr. Fekete
Frigyes Dr. Gorgenyi
Marta Dr. Kovacs
Gizella Dr. Miholics
Gyula Dr. Sebestyen
Istvan Seres
Istvan Dr. Simonyi
Maria Szeli
Pal Dr. Vago
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU7175887A publication Critical patent/AU7175887A/en
Application granted granted Critical
Publication of AU601725B2 publication Critical patent/AU601725B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/30—Metal salts; Chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU71758/87A 1986-04-18 1987-04-16 An organic zinc complex and its use as an antimycotic Ceased AU601725B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1623/86 1986-04-18
HU861623A HU196554B (en) 1986-04-18 1986-04-18 Process for production of medical compounds with fungicidal effect

Publications (2)

Publication Number Publication Date
AU7175887A AU7175887A (en) 1987-10-22
AU601725B2 true AU601725B2 (en) 1990-09-20

Family

ID=10955373

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71758/87A Ceased AU601725B2 (en) 1986-04-18 1987-04-16 An organic zinc complex and its use as an antimycotic

Country Status (24)

Country Link
US (2) US4868172A (fi)
JP (1) JPS62294616A (fi)
KR (1) KR870010036A (fi)
CN (1) CN1021632C (fi)
AU (1) AU601725B2 (fi)
BE (1) BE1001251A4 (fi)
BG (1) BG47945A3 (fi)
CA (1) CA1306685C (fi)
CH (1) CH671880A5 (fi)
CS (1) CS269993B2 (fi)
DE (1) DE3713372A1 (fi)
DK (1) DK200087A (fi)
ES (1) ES2005165A6 (fi)
FI (1) FI871703A (fi)
FR (1) FR2597343B1 (fi)
GB (1) GB2189144B (fi)
GR (1) GR870617B (fi)
HU (1) HU196554B (fi)
IL (1) IL82238A0 (fi)
IT (1) IT1207583B (fi)
NL (1) NL8700906A (fi)
PL (1) PL265249A1 (fi)
SE (1) SE8701592L (fi)
YU (1) YU46313B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355383A1 (de) * 1988-07-28 1990-02-28 Ciba-Geigy Ag Solubilisierungsverfahren
US5219847A (en) * 1989-06-12 1993-06-15 Shiseido Company, Ltd. Antipruritic composition
ATE112962T1 (de) * 1989-06-12 1994-11-15 Shiseido Co Ltd Mittel gegen juckreiz.
US7846919B2 (en) 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
WO2012071577A2 (en) * 2010-11-25 2012-05-31 Zzakey Technologies Ltd. Biodegradable fire-fighting formulation
CN111937886A (zh) * 2019-05-16 2020-11-17 兰州大学 一种8-羟基喹啉配合物的制备及其在防治植物病害中的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU512550B2 (en) * 1975-10-24 1980-10-16 Kemira Kemwood A.B. Antimicrobial agent
AU525546B2 (en) * 1977-11-09 1982-11-11 Procter & Gamble Company, The Zinc erythromycin and therapeutic compositions comprising same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH494760A (de) * 1962-11-30 1970-08-15 Metalsalts Corp Verfahren zur Herstellung von Metall-8-chinolinolaten mit Ausnahme der Alkalimetallderivate
US3886277A (en) * 1967-02-14 1975-05-27 Schwarzkopf Gmbh Hans Methods of controlling dandruff using 5,7-dichloro-8-hydroxy quinoline
BE755584A (fr) * 1969-09-19 1971-03-01 Ugine Kuhlmann Nouveaux medicaments a activite amoebicide
DE2154020A1 (de) * 1971-10-29 1973-05-03 Hoechst Ag Metallkomplexe von substituierten benzimidazolen
DE3129685C2 (de) * 1981-07-28 1986-11-06 geb. Stoffel Annemarie Dr. 7802 Merzhausen Buck Antiseptische Lösung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU512550B2 (en) * 1975-10-24 1980-10-16 Kemira Kemwood A.B. Antimicrobial agent
AU525546B2 (en) * 1977-11-09 1982-11-11 Procter & Gamble Company, The Zinc erythromycin and therapeutic compositions comprising same

Also Published As

Publication number Publication date
HU196554B (en) 1988-12-28
GR870617B (en) 1987-08-18
YU69387A (en) 1988-12-31
KR870010036A (ko) 1987-11-30
US4868172A (en) 1989-09-19
JPS62294616A (ja) 1987-12-22
DK200087D0 (da) 1987-04-15
US4871728A (en) 1989-10-03
CS269993B2 (en) 1990-05-14
DE3713372A1 (de) 1987-10-22
SE8701592L (sv) 1987-10-19
CS203587A2 (en) 1989-04-14
AU7175887A (en) 1987-10-22
FR2597343A1 (fr) 1987-10-23
IL82238A0 (en) 1987-10-30
FI871703A (fi) 1987-10-19
NL8700906A (nl) 1987-11-16
GB8709166D0 (en) 1987-05-20
YU46313B (sh) 1993-05-28
ES2005165A6 (es) 1989-03-01
IT1207583B (it) 1989-05-25
GB2189144A (en) 1987-10-21
FI871703A0 (fi) 1987-04-16
CH671880A5 (fi) 1989-10-13
CN1021632C (zh) 1993-07-21
BE1001251A4 (fr) 1989-09-05
HUT43781A (en) 1987-12-28
IT8720168A0 (it) 1987-04-17
FR2597343B1 (fr) 1991-11-29
SE8701592D0 (sv) 1987-04-16
CA1306685C (en) 1992-08-25
BG47945A3 (en) 1990-10-15
DE3713372C2 (fi) 1991-12-19
JPH0525858B2 (fi) 1993-04-14
CN87102747A (zh) 1987-12-09
DK200087A (da) 1987-10-19
GB2189144B (en) 1990-04-25
PL265249A1 (en) 1988-07-21

Similar Documents

Publication Publication Date Title
US4407803A (en) Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
De la Lande The alkaloids of Cryptocarya pleurosperma.
AU601725B2 (en) An organic zinc complex and its use as an antimycotic
US4196217A (en) Hydroxylated amines with bacteriostatic activity
IE52898B1 (en) Method and compounds for treating enflammatory bowel disease
DD263762A5 (de) Verfahren zur herstellung eines zinkchelatkomplexes des s-chlor-7-jod-8-hydroxychinolin
US5663201A (en) Desferrioxamine-B salts
US5061720A (en) Substituted-4-thiazolidinone derivatives
US4623648A (en) 1-azaxanthone for use as therapeutic agent as an antipyretic, analgesic, anti-inflammatory and bronchodilator
CN102190644B (zh) 手性3-羟基吡啶-4-酮类衍生物及其合成和用途
DE2166359A1 (de) Bis- eckige klammer auf (4-acylamidophenoxy)-alkyl eckige klammer zu -aether und ein verfahren zu ihrer herstellung
DE69328357T2 (de) Komplex von 2-aminoäthansulfonsäure und zink
DE2537294C3 (de) S-Inosyl-L-cystein und Verfahren zu seiner Herstellung
DE2706841C2 (fi)
JPS63284186A (ja) ４−トリアルキルシリルベンジルアミン誘導体、その製造法及び用途
EP0200527A2 (en) Norfloxacin salt
JPH06100569A (ja) シコニン金属錯体化合物
KR100344099B1 (ko) 신규한비페닐디카르복실산유도체와이의제조방법
CA1301776C (en) Compound of choline, a process for its preparation and therapeutic composition containing it
DE1620489A1 (de) Verfahren zur Herstellung von 7-Chlor-4[4-(2-hydroxyaethylamino)-1-methylbutylamino]-chinolin
US4730054A (en) Imidazole thieno-benzothiepins
US4215143A (en) Anti-ulcer pharmaceutical composition containing inositol hexasulfate aluminum or sodium aluminum salt as active ingredient
DE2756067C2 (de) Schwefelhaltige kondensierte Isochinolinon-Verbindungen
EP0153171A2 (en) New 2-hydroxyethyl-trimethylammonium salt of 1-ethyl-3-carboxy-4-oxo-6,7-methylenedioxy-1,4-dihydroquinoline, process for the preparation thereof and pharmaceutical composition containing it
JPH075460B2 (ja) 制癌剤